The content is available as a PDF (933.7 KB).
. 2022 Jul 4;77:S309–S310. doi: 10.1016/S0168-8278(22)00986-2
Immune response and safety in standard and third dose SARS-CoV-2 vaccination in patients with autoimmune hepatitis on immunosupressive therapy, a prospective cohort study
Kristin Jorgensen
, Adity Chopra
, Joseph Sexton
, Anne T Tveter
, Johannes R Hov
, Ingrid Jyssum
, Lise Sofie H Nissen-Meyer
, John T Vaage
, Silje W Syversen
, Guro L Goll
, Fridtjof Lund-Johansen
, Jørgen Jahnsen
Kristin Jorgensen
Find articles by Kristin Jorgensen
Adity Chopra
Find articles by Adity Chopra
Joseph Sexton
Find articles by Joseph Sexton
Anne T Tveter
Find articles by Anne T Tveter
Johannes R Hov
Find articles by Johannes R Hov
Ingrid Jyssum
Find articles by Ingrid Jyssum
Lise Sofie H Nissen-Meyer
Find articles by Lise Sofie H Nissen-Meyer
John T Vaage
Find articles by John T Vaage
Silje W Syversen
Find articles by Silje W Syversen
Guro L Goll
Find articles by Guro L Goll
Fridtjof Lund-Johansen
Find articles by Fridtjof Lund-Johansen
Jørgen Jahnsen
Find articles by Jørgen Jahnsen
Issue date 2022 Jul.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9252385